Dopaminergic agonist and antagonist effects on striatal tyrosine hydroxylase distribution.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003342:Corpus Striatum / Q000201:enzymology*; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D011748:Pyrogallol / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D011748:Pyrogallol; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine